{
  "trial_id": "NCT03699631",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type of hematologic malignancy, disease status at transplantation, conditioning regimen, donor type, HLA match status, left ventricular ejection fraction, creatinine clearance, diffusing capacity of the lungs for carbon monoxide (DLCO), forced expiratory volume (FEV1), total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), Karnofsky Performance Score, history of infections, hepatitis B or C status, HIV status, history of gastrointestinal disorders, history of demyelinating disorders, cardiovascular conditions, serious medical or psychiatric illnesses, pregnancy status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "type of hematologic malignancy",
        "disease status at transplantation",
        "conditioning regimen",
        "donor type",
        "HLA match status",
        "left ventricular ejection fraction",
        "creatinine clearance",
        "diffusing capacity of the lungs for carbon monoxide (DLCO)",
        "forced expiratory volume (FEV1)",
        "total bilirubin",
        "alanine aminotransferase (ALT)",
        "aspartate aminotransferase (AST)",
        "Karnofsky Performance Score",
        "history of infections",
        "hepatitis B or C status",
        "HIV status",
        "history of gastrointestinal disorders",
        "history of demyelinating disorders",
        "cardiovascular conditions",
        "serious medical or psychiatric illnesses",
        "pregnancy status"
      ]
    },
    "processed-gen-response": "Age, gender, type of hematologic malignancy, disease status at transplantation, conditioning regimen, donor type, HLA match status, left ventricular ejection fraction, creatinine clearance, diffusing capacity of the lungs for carbon monoxide (DLCO), forced expiratory volume (FEV1), total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), Karnofsky Performance Score, history of infections, hepatitis B or C status, HIV status, history of gastrointestinal disorders, history of demyelinating disorders, cardiovascular conditions, serious medical or psychiatric illnesses, pregnancy status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Hematologic Malignancy Type, Complete Remission Status, Conditioning Regimen Type, Donor Match Type, Left Ventricular Ejection Fraction, Creatinine Clearance, DLCO, FEV1, Total Bilirubin, ALT, AST, Karnofsky Performance Score, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Hematologic Malignancy Type",
        "Complete Remission Status",
        "Conditioning Regimen Type",
        "Donor Match Type",
        "Left Ventricular Ejection Fraction",
        "Creatinine Clearance",
        "DLCO",
        "FEV1",
        "Total Bilirubin",
        "ALT",
        "AST",
        "Karnofsky Performance Score"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Hematologic Malignancy Type, Complete Remission Status, Conditioning Regimen Type, Donor Match Type, Left Ventricular Ejection Fraction, Creatinine Clearance, DLCO, FEV1, Total Bilirubin, ALT, AST, Karnofsky Performance Score"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Karnofsky Performance Score, Hematologic Malignancy Type, Disease Status at Transplant, Donor Type, Conditioning Regimen, Prior Chemotherapy, Prior Radiation Therapy, Creatinine Clearance, Left Ventricular Ejection Fraction, DLCO, FEV1, Total Bilirubin, ALT, AST.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Score",
        "Hematologic Malignancy Type",
        "Disease Status at Transplant",
        "Donor Type",
        "Conditioning Regimen",
        "Prior Chemotherapy",
        "Prior Radiation Therapy",
        "Creatinine Clearance",
        "Left Ventricular Ejection Fraction",
        "DLCO",
        "FEV1",
        "Total Bilirubin",
        "ALT",
        "AST"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Karnofsky Performance Score, Hematologic Malignancy Type, Disease Status at Transplant, Donor Type, Conditioning Regimen, Prior Chemotherapy, Prior Radiation Therapy, Creatinine Clearance, Left Ventricular Ejection Fraction, DLCO, FEV1, Total Bilirubin, ALT, AST."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, Karnofsky Performance Score, hematologic malignancy type, disease status at alloHCT, donor type, HLA match, conditioning regimen, graft type, left ventricular ejection fraction, estimated creatinine clearance, DLCO, FEV1, total bilirubin, ALT, AST, prior therapies.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Karnofsky Performance Score",
          "Karnofsky Performance Score"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "hematologic malignancy type",
        "disease status at alloHCT",
        "donor type",
        "HLA match",
        "conditioning regimen",
        "graft type",
        "left ventricular ejection fraction",
        "estimated creatinine clearance",
        "DLCO",
        "FEV1",
        "total bilirubin",
        "ALT",
        "AST",
        "prior therapies"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, weight, height, Karnofsky Performance Score, hematologic malignancy type, disease status at alloHCT, donor type, HLA match, conditioning regimen, graft type, left ventricular ejection fraction, estimated creatinine clearance, DLCO, FEV1, total bilirubin, ALT, AST, prior therapies."
  }
}